Key stats
About CONCORD DRUGS LIMITED
Sector
Headquarters
Hyderabad
Founded
1995
Website
ISIN
INE858L01010
FIGI
BBG0084FFX96
Concord Drugs Ltd. engages in the provision of pharmaceutical formulations. Its products include ready to fill pellets, mup's tissue bio adhesive, injectables, oral solid dosages, oral solid dosages, and liquid orals. The company was founded on April 24, 1995 and is headquartered in Hyderabad, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CONCORD is 37.38 INR — it has increased by 1.38% in the past 24 hours. Watch CONCORD DRUGS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange CONCORD DRUGS LIMITED stocks are traded under the ticker CONCORD.
CONCORD stock has fallen by −4.03% compared to the previous week, the month change is a 1.03% rise, over the last year CONCORD DRUGS LIMITED has showed a −10.68% decrease.
CONCORD reached its all-time high on Apr 7, 2015 with the price of 91.25 INR, and its all-time low was 11.68 INR and was reached on Mar 26, 2020. View more price dynamics on CONCORD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CONCORD stock is 7.12% volatile and has beta coefficient of 2.08. Track CONCORD DRUGS LIMITED stock price on the chart and check out the list of the most volatile stocks — is CONCORD DRUGS LIMITED there?
No, CONCORD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CONCORD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONCORD DRUGS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONCORD DRUGS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONCORD DRUGS LIMITED stock shows the buy signal. See more of CONCORD DRUGS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.